Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

47 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Overview of cellular immunotherapy for patients with glioblastoma.
Vauleon E, Avril T, Collet B, Mosser J, Quillien V. Vauleon E, et al. Among authors: avril t. Clin Dev Immunol. 2010;2010:689171. doi: 10.1155/2010/689171. Epub 2010 Oct 4. Clin Dev Immunol. 2010. PMID: 20953324 Free PMC article. Review.
Expression of nine tumour antigens in a series of human glioblastoma multiforme: interest of EGFRvIII, IL-13Ralpha2, gp100 and TRP-2 for immunotherapy.
Saikali S, Avril T, Collet B, Hamlat A, Bansard JY, Drenou B, Guegan Y, Quillien V. Saikali S, et al. Among authors: avril t. J Neurooncol. 2007 Jan;81(2):139-48. doi: 10.1007/s11060-006-9220-3. Epub 2006 Sep 27. J Neurooncol. 2007. PMID: 17004103
Distinct effects of human glioblastoma immunoregulatory molecules programmed cell death ligand-1 (PDL-1) and indoleamine 2,3-dioxygenase (IDO) on tumour-specific T cell functions.
Avril T, Saikali S, Vauleon E, Jary A, Hamlat A, De Tayrac M, Mosser J, Quillien V. Avril T, et al. J Neuroimmunol. 2010 Aug 25;225(1-2):22-33. doi: 10.1016/j.jneuroim.2010.04.003. Epub 2010 May 20. J Neuroimmunol. 2010. PMID: 20493562
Differential analysis of glioblastoma multiforme proteome by a 2D-DIGE approach.
Collet B, Guitton N, Saïkali S, Avril T, Pineau C, Hamlat A, Mosser J, Quillien V. Collet B, et al. Among authors: avril t. Proteome Sci. 2011 Apr 6;9(1):16. doi: 10.1186/1477-5956-9-16. Proteome Sci. 2011. PMID: 21470419 Free PMC article.
Mechanisms of immunomodulation in human glioblastoma.
Avril T, Vauleon E, Tanguy-Royer S, Mosser J, Quillien V. Avril T, et al. Immunotherapy. 2011 Apr;3(4 Suppl):42-4. doi: 10.2217/imt.11.39. Immunotherapy. 2011. PMID: 21524170 Review.
Human glioblastoma stem-like cells are more sensitive to allogeneic NK and T cell-mediated killing compared with serum-cultured glioblastoma cells.
Avril T, Vauleon E, Hamlat A, Saikali S, Etcheverry A, Delmas C, Diabira S, Mosser J, Quillien V. Avril T, et al. Brain Pathol. 2012 Mar;22(2):159-74. doi: 10.1111/j.1750-3639.2011.00515.x. Epub 2011 Sep 16. Brain Pathol. 2012. PMID: 21790828
Proteomic analysis underlines the usefulness of both primary adherent and stem-like cell lines for studying proteins involved in human glioblastoma.
Collet B, Avril T, Aubry M, Hamlat A, Le Reste PJ, Chiforeanu D, Vauleon E, Mosser J, Quillien V. Collet B, et al. Among authors: avril t. J Proteomics. 2014 Oct 14;110:7-19. doi: 10.1016/j.jprot.2014.07.022. Epub 2014 Aug 1. J Proteomics. 2014. PMID: 25088051
Signaling the Unfolded Protein Response in primary brain cancers.
Le Reste PJ, Avril T, Quillien V, Morandi X, Chevet E. Le Reste PJ, et al. Among authors: avril t. Brain Res. 2016 Jul 1;1642:59-69. doi: 10.1016/j.brainres.2016.03.015. Epub 2016 Mar 23. Brain Res. 2016. PMID: 27016056 Review.
Endoplasmic reticulum proteostasis in glioblastoma-From molecular mechanisms to therapeutic perspectives.
Obacz J, Avril T, Le Reste PJ, Urra H, Quillien V, Hetz C, Chevet E. Obacz J, et al. Among authors: avril t. Sci Signal. 2017 Mar 14;10(470):eaal2323. doi: 10.1126/scisignal.aal2323. Sci Signal. 2017. PMID: 28292956 Review.
CD90 Expression Controls Migration and Predicts Dasatinib Response in Glioblastoma.
Avril T, Etcheverry A, Pineau R, Obacz J, Jegou G, Jouan F, Le Reste PJ, Hatami M, Colen RR, Carlson BL, Decker PA, Sarkaria JN, Vauléon E, Chiforeanu DC, Clavreul A, Mosser J, Chevet E, Quillien V. Avril T, et al. Clin Cancer Res. 2017 Dec 1;23(23):7360-7374. doi: 10.1158/1078-0432.CCR-17-1549. Epub 2017 Sep 22. Clin Cancer Res. 2017. PMID: 28939749
47 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback